2007

Renaud S, Leppert D.
Matrix metalloproteinases in neuromuscular disease.
Muscle Nerve. 2007 Jul;36(1):1-13.

Hardmeier M, Haller S, Steck A, Lyrer P, Engelter S, Renaud S.
Vertebral artery dissection presenting with fifth cervical root (C5) radiculopathy.
J Neurol. 2007 May;254(5):672-3.

Sutter R., Arber C., Tichelli A., Steck A.J. and Czaplinski A. Cranial and peripheral neuropathy due to leptomeningeal infiltration in a patient with Waldenstrom’s macroglobulinemia. J Neurol 2007 Aug 3; [Epub ahead of print]

Becker A., Hardmeier M, Steck A. J., Czaplinski A. Primary lateral sclerosis presenting with isolated progressive pseudobulbar syndrome.European Journal of Neurology 14 (8), 2007

2006

Czaplinski A., Haverkamp L.J., Yen A.A., Simpson E.P., Lai E.C., Appel SH. The value of database controls in pilot or futility studies in ALS. Neurology 2006; 67(10): 1827-32

Czaplinski A., Yen A.A., Appel S.H. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry 2006; 77(3): 390-2.

Czaplinski A., Yen A.A., Simpson E.P., Appel SH. Predictability of disease progression in amyotrophic lateral sclerosis. Muscle Nerve 2006; 34(6): 702-8.

Czaplinski A., Yen A.A., Simpson E.P., Appel SH. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotropic lateral sclerosis changing? Arch Neurol 2006; 63(8): 1139-43.

Czaplinski A., Yen A.A., Appel SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol 2006; 253(11): 1428-36.

Czaplinski A., Schweikert K., Strobel W., Steck A.J., Weber M. Symptomatic management in amyotrophic lateral sclerosis (ALS). Schweiz Rundsch Med Prax. 2006; 95(8): 263-71.

Czaplinski A., Appel SH. Amyotrophic lateral sclerosis: can we predict the course of disease? Schweiz Arch Neurol Psychiatrie 2006; 157: 317-22.

Radziwill A.J., Schweikert K., Kuntzer T., Fuhr P., Steck A.J. Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: An open-label study. Eur Neurol 2006; 56(1): 37-8.

Renaud S., Fuhr P., Gregor M., Schweikert K., Lorenz D., Daniels C., Deuschl G., Gratwohl A., Steck A.J. High-dose rituximab and anti-MAG-associated polyneuropathy. Neurology 2006; 66(5): 742-4.

Renaud S. Dysimmune polyneuropathies – new diagnostic and therapeutic insights. Schweiz Arch Neurol Psychiatrie 2006; 157: 307-16.

Schweikert K., Fuhr P., Probst A., Tolnay M., Renaud S., Steck A.J. Contribution of Nerve Biopsy tounclassified Neuropathy. Eur Neurol 2006; 57(2): 86-90

Steck A.J., Erne B., Pareyson D., Sghirlanzoni A., Taroni F., Schaeren-Wiemers N. Normal expression of myelin protein zero with frame-shift mutation correlates with mild phenotype. J Peripher Nerv Syst 2006; 11(1): 61-6.

Steck A.J., Stalder A.K., Renaud S. Anti-myelin-associated glycoprotein neuropathy. Curr Opin Neurol 2006; 19(5): 458-63.

2005

Renaud S., Hays A.P., Brannagan TH 3rd, Sander H.W., Edgar M., Weimer L.H., Olarte M.R., Dalakas M.C., Xiang Z., Danon M.J., Latov N. Gene expression profiling in chronic inflammatory demyelinating polneuropathy. J Neuroimmunol 2005; 159(1-2): 203-14.

Rüegg S., Lehky Hagen M., Hohl U., Kappos L., Fuhr P., Plasilova M., Muller H., Heinimann K. Oculopha-ryngeal muscular dystrophy – an under-diagnosed disorder? Swiss Med Wkly 2005; 135(39-40): 574-86.

2004

Czaplinski A., Steck A. J. Immune mediated neuropathies – an update on therapeutics strategies. J Neurol 2004; 251(2): 127-37.

Czaplinski A., Steck A. J., Andersen P. M., Weber M. Flail arm syndrome: a clinical variant of amyotrophic lateral sclerosis. Eur J Neurol. 2004 Aug;11(8):567-8.

Czaplinski A., Steck A. J., Andersen P. M., Weber M. Flail arm syndrome: a clinical variant of amyotrophic lateral sclerosis. Eur J Neurol 2004; 11(8): 567-8.

Knecht H., Baumberger M., Tobon A., Steck A.J. Sustained remission of CIDP associated with Evans syndrome. Neurology 2004; 63(4): 730-2.

Kuntzer T., Antoine J.C., Steck A.J. Clinical features and pathophysiological basis of sensory neuronopa thies (ganglionopathies). Muscle Nerve 2004; 30(3): 255-68.

Zatov N., Renaud S. Effector mechanisms in anti-MAG antibody-mediated and other demyelinating neuropathies. J Neurol Sci 2004; 220(1-2): 127-9.

Renaud S., Fuhr P. Spontane schmerzhafte Läsion des Medianus-Hauptstammes – eine seltene Variante der neuralgischen Schulteramyotrophie? Akt Neurol 2004; 31:27-9.

Sollberger M., Fluri F., Baumann T., Sonnet S., Tamm M., Steck A.J., Brutsche M. Successful treatment of steroid-refractory neurosarcoidosis with infliximab. J Neurol 2004; 251(6): 760-1.

Valderrabano V., Hintermann B., Wischer T., Fuhr P., Dick W. Recovery of the posterior tibial muscle after late reconstruction following tendon rupture Foot Ankle Int 2004; 25(2): 85-95.

Weber M., The role of genetics in amyotrophic lateral sclerosis. Schweiz Rundsch Med Prax 2004; 93:275-9.